osimertinib
astrazeneca
['adaura', 'aura ,(-laura)']
adaura #asco2023 key data = 43% of patients receiving subsequent anticancer ttt got osi
= very very low 
Medicine, Oncology (sarcoma, H&N, CUP), Research = EBM, Epi, Policy #metaresearch @Hopitaux_unige (Geneva, CH), @vkprasadlab (UCSF). No COI. Views mine.